ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy
35 pages · PDF · 18 August 2025 · Licensed single-user copy, watermarked to the buyer
Tactical Artificial Intelligence, Big Data & Analytics Military Medical Tech Belgium
€499 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
A small Belgian spin-off is quietly reshaping how doctors diagnose lung diseases. ArtiQ emerged from a university lab with a clear vision: use artificial intelligence to interpret complex pulmonary function tests faster and more accurately than human experts.
In just a few years, its software has analyzed tens of thousands of lung tests at Belgian hospitals, proving that machine learning can rival top pulmonologists in detecting conditions like asthma, COPD, and fibrosis . This success has not only attracted patients and physicians – it has also drawn the attention of global industry.
Key questions this report answers
- How does ArtiQ's AI software interpret complex pulmonary function tests to detect conditions such as asthma, COPD and fibrosis?
- How mature is its diagnostic AI, validated on tens of thousands of tests in Belgian hospitals, and what is its dual-use relevance?
- Who are its partners and customers, and what global industry interest has it attracted?
- What capability gaps and dependencies affect this Belgian medical-AI spin-off?
Inside this report
- Executive Summary
- 1. Corporate Identity & Legal Structure
- 2. Strategic Business Profile
- 3. Technology Portfolio Mapping
- 4. Technology Readiness Assessment
- 5. European Strategic Program Participation
- 6. Academic & Research Origins
- 7. Dual-Use Applications & European Market Strategy
- 8. Strategic Partnerships & European Industrial Alliances
- 9. European Market Focus & Operational Domains
- 10. Intellectual Property & European Innovation Assets
- 11. Leadership & European Technical Expertise
- 12. Capability and Gap Analysis
- 13. Strategic Indicators & European Innovation Metrics
Who it's for
Investors screening ArtiQ, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Related reports
Methodology, format & delivery
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (18 August 2025). You receive a 35-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.
Related on DFM
More Tactical reports · Artificial Intelligence, Big Data & Analytics · Military Medical Tech · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →